EUVIMEDEUVIMED entdecken
Crossref

Association of ADAM17 expression with CD4 + and CD8 + tumor-infiltrating lymphocytes in adrenocortical carcinoma and benign adrenal adenoma

Mehmet Sözen iD, Seda Duman Öztürk iD, Alev Selek iD, Berrin Çetinarslan iD, Zeynep Cantürk iD, Emre Gezer iD, Sibel Balcı iD

Endocrine · 2026

DOI: 10.1007/s12020-026-04764-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, 2026. Verfasst von Mehmet Sözen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Kocaeli University Faculty of Medicine, Kocaeli, Turkey, Türkiye. mehmetsozen07@gmail.com. Hauptthemen laut MEDLINE: ADAM17 Protein, Lymphocytes, Tumor-Infiltrating, Adrenal Cortex Neoplasms, Adrenocortical Carcinoma. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Kocaeli University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine malignancy. Although immune checkpoint signaling and tumor-infiltrating lymphocytes (TILs) have been implicated in ACC biology, the role of ADAM10 and ADAM17 in the adrenocortical tumor immune microenvironment remains poorly understood. This study aimed to evaluate the expression of ADAM10, ADAM17, PD-L1, CD4, and CD8 in ACC and benign adrenal adenoma (BAA) tissues.

Methods

This retrospective study included 21 patients with histopathologically confirmed ACC and 39 patients with BAA. Immunohistochemical staining for ADAM10, ADAM17, PD-L1, CD4, and CD8 was performed on formalin-fixed paraffin-embedded tissue samples. ADAM10 and ADAM17 expression were assessed using H-scores, while CD4 + and CD8 + TIL counts were quantified by cell counting. Comparative and correlation analyses were conducted.

Results

ACC tissues exhibited significantly higher CD4 + and CD8 + TIL counts than BAA tissues ( p = 0.010 and p = 0.006, respectively). No significant differences were observed between the groups regarding ADAM10, ADAM17, or PD-L1 expression (all p > 0.05). ADAM17 H-scores showed significant positive correlations with both CD4 + and CD8 + TIL counts in ACC and BAA. No significant associations were found between ADAM10, ADAM17, or PD-L1 expression and Ki-67 index, tumor size, or ENSAT stage.

Conclusions

In this cohort, ACC tissues showed higher CD4 + and CD8 + TIL counts than BAA tissues. Although ADAM10, ADAM17, and PD-L1 expression did not differ significantly between malignant and benign tumors, ADAM17 expression was positively associated with TIL count. These findings warrant further investigation of the potential relationship between ADAM17 and the immune microenvironment of adrenocortical tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinLymphocytes, Tumor-InfiltratingAdrenal Cortex NeoplasmsAdrenocortical CarcinomaCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesAdrenocortical AdenomaAdrenal Gland NeoplasmsAdenomaHumansFemaleMiddle AgedMaleRetrospective StudiesAdultAgedYoung Adult

Stichwörter der Autor:innen

ADAM17Adrenal adenomaAdrenocortical carcinomaImmune microenvironmentTumor-infiltrating lymphocytes

Substanzen

ADAM17 ProteinADAM17 protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Kocaeli University Faculty of Medicine, Kocaeli, Turkey, Türkiye. mehmetsozen07@gmail.com.
  • Department of Pathology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey, Türkiye.
  • Department of Endocrinology and Metabolism, Kocaeli University Faculty of Medicine, Kocaeli, Turkey, Türkiye.
  • Department of Biostatistics and Medical Informatics, University of Kocaeli, Kocaeli, Turkey.

ORCID-Profile: Mehmet Sözen, Seda Duman Öztürk, Alev Selek, Berrin Çetinarslan, Zeynep Cantürk, Emre Gezer, Sibel Balcı

Förderung

  • Kocaeli University Scientific Research Projects Coordination Unit

Zitieren

APA

Sözen, M., Duman Öztürk, S., Selek, A., Çetinarslan, B., Cantürk, Z., Gezer, E., & Balcı, S. (2026). Association of ADAM17 expression with CD4 + and CD8 + tumor-infiltrating lymphocytes in adrenocortical carcinoma and benign adrenal adenoma. Endocrine. https://doi.org/10.1007/s12020-026-04764-8

Vancouver

Sözen M, Duman Öztürk S, Selek A, Çetinarslan B, Cantürk Z, Gezer E, et al. Association of ADAM17 expression with CD4 + and CD8 + tumor-infiltrating lymphocytes in adrenocortical carcinoma and benign adrenal adenoma. Endocrine. 2026. doi:10.1007/s12020-026-04764-8

BibTeX
@article{Szen2026,
  author = {Sözen, Mehmet and Duman Öztürk, Seda and Selek, Alev and Çetinarslan, Berrin and Cantürk, Zeynep and Gezer, Emre and Balcı, Sibel},
  title = {Association of ADAM17 expression with CD4 + and CD8 + tumor-infiltrating lymphocytes in adrenocortical carcinoma and benign adrenal adenoma},
  journal = {Endocrine},
  year = {2026},
  doi = {10.1007/s12020-026-04764-8}
}
Kostenlos starten →